* Medifast Inc reported quarterly adjusted earnings of 35 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $2.12. The mean expectation of two analysts for the quarter was for a loss of 28 cents per share. Wall Street expected results to range from -40 cents to -15 cents per share.

* Revenue fell 40.6% to $140.16 million from a year ago; analysts expected $134.15 million.

* Medifast Inc's reported EPS for the quarter was 10 cents​.

* The company reported quarterly net income of $1.13 million.

* Medifast Inc shares had fallen by 1.7% this quarter and lost 72.0% so far this year.

FORECAST CHANGES

* The mean earnings estimate of analysts was unchanged in the last three months.​

* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."

* The average consensus recommendation for the food processing peer group is "sell."

Wall Street's median 12-month price target for Medifast Inc is $17.25 This summary was machine generated from LSEG data November 5 at 07:42 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,

MISSED

Sep. 30 2024 -0.28 0.35 Beat

Jun. 30 2024 0.39 0.92 Beat

Mar. 31 2024 0.78 0.66 Missed

Dec. 31 2023 0.96 0.55 Missed